(4 years, 10 months ago)
Commons ChamberMy constituency of South Cambridgeshire is no less than the life sciences capital of the world. We have the global headquarters of AstraZeneca, 20,000 people working in the biomedical campus around Addenbrooke’s Hospital and dozens of industrial parks and small businesses developing new therapies, helping people to live longer and healthier. Many of those companies are dependent on research grants, some of which come from the EU. Will my hon. Friend tell me what work the Government are doing to ensure that South Cambridge remains the biomedical and life sciences capital of the world, and that companies have continuity of funding once we leave the EU?
I welcome my hon. Friend to his place. He represents an area that is the life sciences crucible of Europe and, as science Minister, I am determined to ensure that that continues. I will meet the vice-chancellor, Stephen Toope, shortly to talk about Cambridge’s own plans for investment for the future.
On European investment, I want to make it perfectly clear to the House that when it comes to Horizon 2020, including European Research Council grants and Marie Skłodowska-Curie actions, the withdrawal agreement ensures that we can continue within that framework. When it comes to looking at Horizon Europe, its successor scheme, we want to explore an association that is as full as possible. We may be leaving the EU, but we will not be leaving our European research partnerships.